Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea

Journal of Infection

Volumn 54, Issue 2, 2007, Pages 185-191

  Kim, Seong Man ^a   Lee, Ki Sung ^a   Park, Chi Jun ^a   Lee, Ja Young ^a   Kim, Kyung Ho ^a   Park, Joon Yong ^a   Lee, Jin Heon ^a   Kim, Hak Yang ^a   Yoo, Jae Young ^a   Jang, Myoung Kuk ^a  

^a Hallym University Medical Center   (South Korea)

Author keywords

HBsAg negative; HBV DNA; Nested PCR; Occult HBV infection

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SOUTH KOREA; VIRUS GENOME; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 33846148318     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.02.002     Document Type: Article

References (32)

1. Chun B.Y., Lee M.K., and Rho Y.K. The prevalence of hepatitis B surface antigen among Korean by literature review. Korean J Epidemiol 14 (1992) 54-62
2. Jang M.K., Lee J.Y., Lee J.H., Kim Y.B., Kim H.Y., Lee M.S., et al. Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 16 (2001) 153-159
3. Lee D.H., Kim J.H., Nam J.J., Kim H.R., and Shin H.R. Epidemiological findings of hepatitis B infection based on 1998 national health and nutrition survey in Korea. J Korean Med Sci 17 (2002) 457-462
4. Hu K.Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9 (2002) 243-257
5. Chan H.L., Tsang S.W., Leung N.W., Tse C.H., Hui Y., Tam J.S., et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol 97 (2002) 1211-1215
6. Ding X., Park Y.N., Taltavull T.C., Thung S.N., Jin X., Jin Y., et al. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Jpn J Infect Dis 56 (2003) 12-18
7. Hoofnagle J.H., Seeff L.B., Bales Z.B., and Zimmerman H.J. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298 (1978) 1379-1383
8. Torbenson M., and Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2 (2002) 479-486
9. Besisik F., Karaca C., Akyuz F., Horosanli S., Onel D., Badur S., et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 38 (2003) 506-510
10. Torbenson M., Kannangai R., Astemborski J., Strathdee S.A., Vlahov D., and Thomas D.L. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 39 (2004) 51-57
11. Idilman R., Arat M., Soydan E., Toruner M., Soykan I., Akbulut H., et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat 11 (2004) 141-147
12. Paterlini P., Gerken G., Nakajima E., Terre S., D'Errico A., Grigioni W., et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 323 (1990) 80-85
13. Brechot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., and Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?. Hepatology 34 (2001) 194-203
14. Fang Z.L., Zhuang H., Wang X.Y., Ge X.M., and Harrison T.J. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol 10 (2004) 3264-3268
15. Kannangai R., Molmenti E., Arrazola L., Klein A., Choti M., Thomas D.L., et al. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat 11 (2004) 297-301
16. Komori M., Yuki N., Nagaoka T., Yamashiro M., Mochizuki K., Kaneko A., et al. Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients. J Hepatol 35 (2001) 798-804
17. Minuk G.Y., Sun D.F., Greenberg R., Zhang M., Hawkins K., Uhanova J., et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40 (2004) 1072-1077
18. Shiota G., Oyama K., Udagawa A., Tanaka K., Nomi T., Kitamura A., et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 62 (2000) 151-158
19. Zervou E.K., Dalekos G.N., Boumba D.S., and Tsianos E.V. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 41 (2001) 652-658
20. Luo K.X., Zhou R., He C., Liang Z.S., and Jiang S.B. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 35 (1991) 55-59
21. Shih L.N., Sheu J.C., Wang J.T., Huang G.T., Yang P.M., Lee H.S., et al. Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J Med Virol 32 (1990) 257-260
22. Wang J.T., Wang T.H., Sheu J.C., Shih L.N., Lin J.T., and Chen D.S. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 163 (1991) 397-399
23. Cacciola I., Pollicino T., Squadrito G., Cerenzia G., Orlando M.E., and Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341 (1999) 22-26
24. Mariscal L.F., Rodriguez-Inigo E., Bartolome J., Castillo I., Ortiz-Movilla N., Navacerrada C., et al. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum. J Med Virol 73 (2004) 177-186
25. Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Crax A., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 (2004) 102-110
26. Joo K.R., Bang S.J., Song B.C., Youn K.H., Joo Y.H., Yang S., et al. Hepatitis B viral markers of Korean adults in the late 1990s: survey data of 70,347 health screenees. Korean J Gastroenterol 33 (1999) 642-652
27. Blackberg J., and Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 33 (2000) 992-997
28. Loriot M.A., Marcellin P., Walker F., Boyer N., Degott C., Randrianatoavina I., et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27 (1997) 251-258
29. NIH. Infectious disease testing for blood transfusions. NIH consensus development panel on infectious disease testing for blood transfusions. JAMA 274 (1995) 1374-1379
30. Hwang S., Moon D.B., Lee S.G., Park K.M., Kim K.H., Ahn C.S., et al. Safety of anti-hepatitis B core antibody-positive donors for living-donor liver transplantation. Transplantation 75 (2003) S45-S48
31. Allain J.P. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83-91
32. Prince A.M., Stephan W., and Brotman B. Beta-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives. Rev Infect Dis 5 (1983) 92-107